FFT Wealth Management’s Pfizer PFE Stock Holding History

FFT Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8,122	Closed	-$259K	–	63
2017 Q2	$259K	Buy	+8,122	New	+$256K	0.08%	75

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FFT Wealth Management's PFE Position: Q3 2017 in Review

FFT Wealth Management sold out of Pfizer (PFE) in Q3 2017, closing a stake of 8,122 shares — an estimated $259K sold.

FFT Wealth Management first reported a position in PFE in Q2 2017 and held it in 1 quarter. The position peaked at $259K in Q2 2017. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

FFT Wealth Management reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
FFT Wealth Management sold 8,122 Pfizer shares in Q3 2017, an estimated $259K.
FFT Wealth Management first reported a position in Pfizer in Q2 2017 and held it in 1 quarter.
FFT Wealth Management's Pfizer position peaked at $259K in Q2 2017.
2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on FFT Wealth Management's 13F filing for Q3 2017, filed 14 Nov 2017.